创伤患者中增高的肾脏清除率的识别:创伤重症监护增高的肾脏清除率评分系统的验证
研究连续纳入2015年3月至2016年1月入住ICU、测得肌酐清除率(CrCl)且血清肌酐(SCr)不大于1.3 mg/dL的创伤患者133例,ARC定义为实测CrCl≥130 mL/min。多因素分析显示年龄小于56岁(OR 58.3)、年龄56至75岁(OR 13.5)、SCr小于0.7 mg/dL(OR 12.5)和男性(OR 6.9)为ARC危险因素,据此构建ARCTIC评分。ROC曲线下面积0.813(95%CI 0.735-0.892,P<0.001),评分≥6分筛查ARC的敏感度0.843、特异度0.682、阳性预测值0.843、阴性预测值0.682。作者认为该评分简便,可在床旁应用。
要点
- 创伤ICU患者ARC(实测CrCl≥130 mL/min)发生率为67%。
- ARC独立危险因素:年龄小于56岁OR 58.3(95%CI 5.2-658.9)、年龄56至75岁OR 13.5(95%CI 1.2-151.7)、SCr小于0.7 mg/dL OR 12.5(95%CI 3-52.6)、男性OR 6.9(95%CI 1.9-24.9)。
- ARCTIC评分:年龄小于56岁4分,年龄56至75岁3分,SCr小于0.7 mg/dL 3分,男性2分。
- ARCTIC评分ROC曲线下面积0.813(95%CI 0.735-0.892,P<0.001)。
- 评分≥6分筛查ARC的敏感度0.843、特异度0.682、阳性预测值0.843、阴性预测值0.682;作者认为此时应考虑调整抗菌药物。
适用人群与场景
- 2015年3月至2016年1月入住ICU的连续创伤患者,且测定了肌酐清除率。
- 排除血清肌酐大于1.3 mg/dL的患者。
诊断标准与关键阈值
- ARC定义为实测肌酐清除率≥130 mL/min。
- ARCTIC评分≥6分作为筛查ARC的切点。
处置流程与药物剂量
- 床旁计算ARCTIC评分:年龄小于56岁计4分,年龄56至75岁计3分,SCr小于0.7 mg/dL计3分,男性计2分。
- ARCTIC评分≥6分时,作者认为应考虑调整抗菌药物剂量。
研究设计与关键结果
- 研究类型为预后/流行病学研究,证据等级III;连续纳入创伤ICU患者133例,平均年龄48±19岁,平均SCr 0.8±0.2 mg/dL,平均实测CrCl 168±65 mL/min,ARC发生率67%。
- 多因素分析:年龄小于56岁OR 58.3(95%CI 5.2-658.9);年龄56至75岁OR 13.5(95%CI 1.2-151.7);SCr小于0.7 mg/dL OR 12.5(95%CI 3-52.6);男性OR 6.9(95%CI 1.9-24.9)。
- ARCTIC评分ROC曲线下面积0.813(95%CI 0.735-0.892),P<0.001。
- ARCTIC评分≥6分筛查ARC:敏感度0.843、特异度0.682、阳性预测值0.843、阴性预测值0.682。
证据类型、等级与局限
- 证据类型:预后/流行病学研究,原文标注证据等级III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对创伤ICU患者可用ARCTIC评分床旁筛查ARC,评分≥6分者作者认为应考虑调整抗菌药物剂量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Augmented renal clearance (ARC) is common in trauma patients and associated with subtherapeutic antimicrobial concentrations. This study reported the incidence of ARC, identified ARC risk factors, and described a model to predict ARC (i.e., ARCTIC) that is specific to trauma patients.
METHODS: Consecutive trauma patients who were admitted to the intensive care unit between March 2015 and January 2016 and had a measured creatinine clearance (CrCl) were considered for inclusion. Patients were excluded if their serum creatinine (SCr) was greater than 1.3 mg/dL. ARC was defined as a measured CrCl of 130 mL/min or greater. Demographic and trauma-specific variables were then compared, and multivariate analysis was performed. Using these results, a weighted scoring system was constructed and evaluated using receiver operating characteristic curve analysis. ARCTIC score cutoffs were chosen based on sensitivity, specificity, positive predictive value, and negative predictive value. The derived scoring system was then compared to a previously published scoring system for accuracy.
RESULTS: There were 133 patients with a mean age of 48 ± 19 years and SCr of 0.8 ± 0.2 mg/dL. The mean measured CrCl was 168 ± 65 mL/min, and the incidence of ARC was 67%. Multivariate analysis revealed the following risk factors for ARC (age, <56: odds ratios [OR], 58.3; 95% confidence interval [CI], 5.2-658.9; age, 56 to 75: OR, 13.5; 95% CI, 1.2-151.7), SCr less than 0.7 mg/dL (OR, 12.5; 95% CI, 3-52.6), and male sex (OR, 6.9; 95% CI, 1.9-24.9). Using these results, the ARCTIC scoring system was: 4 points if younger than 56 years, 3 points if aged 56 years to 75 years, 3 points if SCr less than 0.7 mg/dL, and 2 points if male sex. Receiver operating characteristic curve analysis revealed an area (95% CI) of 0.813 (0.735-0.892) (p < 0.001). An ARCTIC score of 6 or higher had a sensitivity, specificity, positive predictive value, and negative predictive value of 0.843, 0.682, 0.843, and 0.682, respectively.
CONCLUSION: The incidence of ARC in trauma patients is high. The ARCTIC score represents a practical, pragmatic system that can be easily applied at the bedside. An ARCTIC score of 6 or higher represents an appropriate cutoff to screen for ARC where antimicrobial adjustments should be considered.
LEVEL OF EVIDENCE: Prognostic/epidemiologic study, level III.
参考来源
- Barletta JF, Mangram AJ, Byrne M, et al. Identifying augmented renal clearance in trauma patients: Validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system. J Trauma Acute Care Surg. 2017. PMID: 28129261. doi:10.1097/TA.0000000000001387
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。